SSO-ASTRO Consensus Guidance Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer

Similar documents
What are Adequate Margins of Resection for Breast-Conserving Therapy?

What is an Adequate Lumpectomy Margin in 2018?

Radiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging

Resection Margins in Breast Conserving Surgery. Alberto Costa, MD Canton Ticino Breast Unit Lugano, Switzerland

Consensus Guideline on Accelerated Partial Breast Irradiation

Ahmad Elahi*, Gholamreza Toogeh,Habibollah Mahmoodzadeh, Behnaz Jahanbin, Farhad Shahi,

Surgical Margins in Breast Cancer: Finally Defined?

RADIOTHERAPY IN BREAST CANCER :

Consensus Guideline on Breast Cancer Lumpectomy Margins

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.

DCIS: Margins and the USC/VNPI

Breast Conservation Therapy

BREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO

Protocol of Radiotherapy for Breast Cancer

Image guided core biopsies:

Angela Gilliam, MD University of Colorado Surgical Grand Rounds November 3, 2008

Surgical Therapy: Sentinel Node Biopsy and Breast Conservation

Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Bruno CUTULI Policlinico Courlancy REIMS. WORKSHOP SULL IRRADIAZIONE MAMMARIA IPOFRAZIONATA Il carcinoma duttale in situ

Why Do Axillary Dissection? Nodal Treatment and Survival NSABP B04. Revisiting Axillary Dissection for SN Positive Patients

IORT What We ve Learned So Far

Intraoperative. Radiotherapy

Implications of ACOSOG Z11 for Clinical Practice: Surgical Perspective

Speaker s Bureau. Travel expenses. Advisory Boards. Stock. Genentech Invuity Medtronic Pacira. Faxitron. Dune TransMed7 Genomic Health.

Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy

New Technologies in Radiation Oncology. Catherine Park, MD, MPH Advocate Good Shepherd Hospital

Whole Breast Irradiation: Class vs. Hypofractionation

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015

Conservative Surgery and Radiation Stage I and II Breast Cancer

Breast Specimen Processing and Reporting With an Emphasis on Margin Evaluation. A College of American Pathologists Survey of 866 Laboratories

Approved Date: 6/2011, 8/2014 Approval By: Allina Health Breast Program Committee. Departments, Divisions, Operational Areas

ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER

The Role of a Boost Radiation Dose in Patients with Negative Re-Excision Findings

Contralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks

Recent Updates in Surgical Management of Breast Cancer Asian Patient's Perspective

2017 San Antonio Breast Cancer Symposium: Local Therapy Highlights

Classifying Local Disease Recurrences after Breast Conservation Therapy Based on Location and Histology

RESEARCH ARTICLE. Somchai Thanasitthichai 1,2 *, Arkom Chaiwerawattana 2, Oradee Phadhana- Anake 2. Abstract. Introduction

ANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:

Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction

Surgical Pathology Issues of Practical Importance

Clinical outcomes of patients treated with accelerated partial breast irradiation with high-dose rate brachytherapy: Scripps Clinic experience

Disclosure. Objectives 03/19/2019. Current Issues in Management of DCIS Radiation Oncology Considerations

doi: /j.ijrobp

Recurrence, new primary and bilateral breast cancer. José Palacios Calvo Servicio de Anatomía Patológica

How can we Personalize RT as part of Breast-Conserving Therapy?

a SpringerOpen Journal

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Use of a Protease Activated System for Real-time Breast Cancer Lumpectomy Margin Assessment

SFMC Breast Cancer Site Study: 2011

Breast Cancer. Saima Saeed MD

Clinical Trials of Proton Therapy for Breast Cancer. Andrew L. Chang, MD 張維安 Study Chair

BREAST CONSERVATION TREATMENT IN EARLY STAGE DISEASE AND DCIS LAWRENCE J. SOLIN, MD, FACR, FASTRO

Results of the ACOSOG Z0011 Trial

Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer

One Breast Cancer Annual Report

San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy

Radiation Treatment for Breast. Cancer. Melissa James Radiation Oncologist August 2015

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

BREAST MRI. Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School

Breast Cancer. Dr. Andres Wiernik 2017

Principles of breast radiation therapy

Nehmat Houssami, MD, PhD 1, Petra Macaskill, PhD 1, M. Luke Marinovich, MPH 1, and Monica Morrow, MD 2

PRACTICE GUIDELINE FOR BREAST CONSERVATION THERAPY IN THE MANAGEMENT OF INVASIVE BREAST CARCINOMA

Mastectomy For Treatment, For Prevention, For Prophylaxis Not as Simple as Following Data

Treatment Results and Prognostic Factors of Early Breast Cancer Treated with a Breast Conserving Operation and Radiotherapy

Ductal Carcinoma-in-Situ: New Concepts and Controversies

Early and locally advanced breast cancer: diagnosis and management

Corporate Medical Policy

Hypofractionated Radiotherapy for breast cancer: Updated evidence

Local recurrence in lumpectomy patients after imprint cytology margin evaluation

SENTINEL LYMPH NODE BIOPSY FOR PATIENTS WITH EARLY-STAGE BREAST CANCER

Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery

Is Lobular Carcinoma In Situ as a Component of Breast Carcinoma a Risk Factor for Local Failure after Breast-Conserving Therapy?

Should Breast Density Influence Patient Selection for Breast-Conserving Surgery?

Radiation Therapy for the Oncologist in Breast Cancer

Review Article Role of the Radiotherapy Boost on Local Control in Ductal Carcinoma In Situ

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

Current Status of Accelerated Partial Breast Irradiation. Julia White MD Professor, Radiation Oncology

Breast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina

The Challenge of Individualizing Loco-Regional Treatments for Patients with Localized Breast Cancer

Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins During Breast-Conserving Surgery

Journal of Clinical Oncology, Vol 8, No 1 (January), 1990: pp

Ductal Carcinoma In Situ: Review of the Role of Radiation Therapy and Current Controversies

Case Scenario 1 History and Physical 3/15/13 Imaging Pathology

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

The Neoadjuvant Model as a Translational Tool for Drug and Biomarker Development in Breast Cancer

The Use of the Latissimus dorsi Flap in Breast Reconstruction of Post-Mastectomy Patients: Is Superior to the Use of Expander / Prosthesis?

abstract n engl j med 373;6 nejm.org August 6,

Quality ID #263: Preoperative Diagnosis of Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Supplementary Online Content

Advances in Breast Cancer

Objectives Intraoperative Radiation Therapy for Early Stage Breast Cancer

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

Case Scenario 1: This case has been slightly modified from the case presented during the live session to add clarity.

EARLY STAGE BREAST CANCER AND THE EMERGING ROLE OF IORT

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Is Intraoperative Frozen Section Analysis of Reexcision Specimens of Value in Preventing Reoperation in Breast-Conserving Therapy?

Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate surgical options

Transcription:

SSO-ASTRO Consensus Guidance Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer Dr. Yvonne Tsang St. Paul s Hospital

Introductions Breast-conserving therapy (BCT) was introduced more than 40 years and became standard practice for more than 20 years. BCT followed by whole-breast radiation therapy (WBRT) Equivalent survival to mastectomy for stages I and II breast cancer Derby S, McGale P, Correa C, et al. Lancet. 2011;378:1707-16 Fisher B, Anderson S, Bryant J, et al. N Eng J Med. 2002;347:1233-41

Introductions There is still no consensus on what constitutes an optimal negative margin width (3+4) Approximately ¼ women attempting BCT undergo re-excision ½ of them had negative margin, only to achieve a wider clear margin McCahill LE, Single RM, Aiello Bowles EJ, et al. JAMA. 2012;307:467-75 Morrow M, Jagsi R, Alderman AK, et al. JAMA. 2009;302:1551-6

Introductions Society of Surgical Oncology (SSO), in collaboration with the American Society of Radiation Oncology (ASTRO), convened a multidisciplinary expert panel Examining the relationship between margin width and IBTR

Primary question.. What margin width minimizes the risk of IBTR?

Introductions A meta-analysis of margin width and (IBTR) from a systematic review of 33 studies including 28,162 patients Tumor histology, patient age, use of systemic therapy and technique of radiation therapy also examined

Results from meta-analysis Positive margins (ink on invasive carcinoma or ductal carcinoma in situ) are associated with a two-fold increase in the risk of IBTR compared to negative margins. This increased risk is not mitigated by favorable biology, endocrine therapy or a radiation boost. Meena S. Moran, Stuart J. Shnitt, Armando E. Giuliano, et al. Ann Surg Oncol (2014)21:704-16

Results from meta-analysis More widely clear margins than no ink on tumor do not significantly decrease the rate of IBTR. There is no evidence that more widely clear margins reduce IBTR for young patients, unfavorable biology, lobular cancers, or cancers with an extensive intraductal component Meena S. Moran, Stuart J. Shnitt, Armando E. Giuliano, et al. Ann Surg Oncol (2014)21:704-16

Recommendations positive margins A positive margin ink on invasive cancer or DCIS at least a two-fold increase in IBTR This increased risk in IBTR is not nullified by Delivery of a boost dose of radiation Delivery of systemic therapy (endocrine, chemotherapy, or biologic), or Favorable biology

Recommendations Negative Margin Widths Negative margins (no ink on tumor) minimize the risk of IBTR Wider margin widths do not significantly lower this risk The routine practice to obtain wider negative margin widths than no ink on tumor is not indicated

Recommendations Systemic Therapy What are the effects of endocrine or biologically targeted therapy or systemic chemotherapy on IBTR? The rates of IBTR are reduced with the use of systemic therapy. Should a patient who is not receiving any systemic treatment have wider margin widths? In the uncommon circumstance of a patient not receiving adjuvant systemic therapy, there is no evidence suggesting that margins wider than no ink on tumor are needed.

Recommendations Biologic Subtypes Should unfavorable biologic subtypes (triplenegative breast cancers) require wide margins? Margins wider than no ink on tumor are not indicated based on biologic subtype

Recommendations Radiation Therapy Delivery Should margin width be taken into consideration when determining WBRT delivery technique? The choice of whole breast radiation delivery technique, fractionation, and boost dose should not be dependent on the margin width

Recommendations lobular carcinoma Wider negative margins than no ink on tumor are not indicated for invasive lobular carcinoma Classic LCIS at the margin is not an indication for reexcision The significance of pleomorphic LCIS at the margin is uncertain

Recommendations Young age Young age ( 40 years) is associated with both increased IBTR after BCT as well as increased local relapse on the chest wall after mastectomy More frequently associated with adverse biologic and pathologic features There is no evidence that increased margin width nullifies the increased risk of IBTR in young patients

Recommendations - EIC What is the significance of an extensive intraductal component (EIC) in the tumor specimen, and how does this pertain to margin width? An EIC identifies cases that may have a large residual DCIS burden after lumpectomy There is no evidence of an association between increased risk of IBTR and EIC when margins are negative

The End